---
title: "Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293663940.md"
description: "Eli Lilly & Co. (LLY) shares rose 1.97% to $1,185.87 on Thursday, outperforming competitors like Johnson & Johnson, Pfizer, and AbbVie despite a broader market decline where the S&P 500 fell 1.21%. The stock closed 5.09% below its 52-week high of $1,249.45. Trading volume was lower than the 50-day average."
datetime: "2026-07-23T20:32:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293663940.md)
  - [en](https://longbridge.com/en/news/293663940.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293663940.md)
generator: "portal-rs"
---

# Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Eli Lilly & Co. (LLY) rose 1.97% to $1,185.87 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

Eli Lilly & Co. closed 5.09% short of its 52-week high of $1,249.45, which the company reached on July 7th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $259.27, Pfizer Inc. (PFE) rose 0.77% to $25.01, and AbbVie Inc. (ABBV) rose 1.43% to $256.92.

Trading volume (1.9 M) remained 1.2 million below its 50-day average volume of 3.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-23-26 1632ET

### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Evolve Private Wealth LLC Lowers Stock Holdings in Eli Lilly and Company $LLY](https://longbridge.com/en/news/297282696.md)
- [Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label](https://longbridge.com/en/news/297356212.md)
- [Is Eli Lilly Stock Outperforming the Dow?](https://longbridge.com/en/news/297309786.md)
- [Eli Lilly's Taltz-Zepbound Combo Shows Encouraging Results At Week 52](https://longbridge.com/en/news/297510647.md)
- [BIOA_B: Leqembi sales and royalties surged, partnerships expanded, and cash reserves remained strong](https://longbridge.com/en/news/296995614.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**